Td Private Client Wealth LLC Charles River Laboratories International, Inc. Transaction History

Td Private Client Wealth LLC

$3.48 Trillion
Q3 2024

A detailed history of Td Private Client Wealth LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 9,342 shares of CRL stock, worth $1.81 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,342

Previous 12,225 23.58%

Holding current value

$1.81 Million

Previous $2.53 Billion 27.14%

% of portfolio

0.05%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 18, 2024	SELL	$187.96 - $245.29 $541,888 - $707,171	-2,883 Reduced 23.58%	9,342 $1.84 Billion
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $2.52 Million - $3.29 Million	12,225 New	12,225 $2.53 Billion
Q1 2024 Aug 16, 2024	BUY	$203.52 - $273.43 $531,594 - $714,199	2,612 Added 27.1%	12,249 $3.32 Billion
Q4 2023 Aug 16, 2024	SELL	$164.52 - $238.84 $43,268 - $62,814	-263 Reduced 2.66%	9,637 $2.28 Billion
Q3 2023 Aug 16, 2024	SELL	$194.44 - $217.61 $144,663 - $161,901	-744 Reduced 6.99%	9,900 $1.94 Billion
Q2 2023 Aug 16, 2024	SELL	$183.71 - $210.25 $10,104 - $11,563	-55 Reduced 0.51%	10,644 $2.24 Billion
Q1 2023 Aug 16, 2024	SELL	$191.89 - $259.92 $65,626 - $88,892	-342 Reduced 3.1%	10,699 $2.16 Billion
Q4 2022 Aug 16, 2024	SELL	$197.11 - $250.07 $307,294 - $389,859	-1,559 Reduced 12.37%	11,041 $2.41 Billion
Q3 2022 Aug 16, 2024	SELL	$182.44 - $250.54 $54,732 - $75,162	-300 Reduced 2.33%	12,600 $2.48 Billion
Q2 2022 Aug 16, 2024	SELL	$204.13 - $302.4 $145,748 - $215,913	-714 Reduced 5.24%	12,900 $2.76 Billion
Q1 2022 Aug 16, 2024	BUY	$255.51 - $362.11 $354,903 - $502,970	1,389 Added 11.36%	13,614 $3.87 Billion
Q4 2021 Aug 16, 2024	SELL	$351.38 - $448.68 $223,126 - $284,911	-635 Reduced 4.94%	12,225 $4.61 Billion
Q3 2021 Aug 16, 2024	BUY	$372.64 - $458.3 $236,626 - $291,020	635 Added 5.19%	12,860 $5.31 Billion
Q2 2021 Aug 16, 2024	SELL	$294.17 - $371.65 $2.01 Million - $2.54 Million	-6,844 Reduced 34.74%	12,854 $4.75 Billion
Q1 2021 Aug 16, 2024	SELL	$249.67 - $299.48 $29,710 - $35,638	-119 Reduced 0.6%	19,698 $5.71 Billion
Q4 2020 Aug 16, 2024	BUY	$222.0 - $252.62 $138,528 - $157,634	624 Added 3.25%	19,817 $4.95 Billion
Q3 2020 Aug 16, 2024	SELL	$175.56 - $226.45 $50,912 - $65,670	-290 Reduced 1.49%	19,193 $4.35 Billion
Q2 2020 Aug 16, 2024	BUY	$118.84 - $189.72 $210,109 - $335,424	1,768 Added 9.98%	19,483 $3.4 Billion
Q1 2020 Aug 16, 2024	SELL	$98.9 - $178.34 $96,724 - $174,416	-978 Reduced 5.23%	17,715 $2.24 Billion
Q4 2019 Aug 16, 2024	BUY	$126.05 - $152.76 $815,291 - $988,051	6,468 Added 52.91%	18,693 $2.86 Billion

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.88B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Charles River Laboratories International, Inc. Transaction History